POCI vs DBVT vs VIAV vs ALKS vs LITE

For growth investors, Lumentum Holdings Inc.

(LITE) is the stronger pick with 21. 0% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 5x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

5x versus Lumentum Holdings Inc. at 2441. 7x. On forward P/E, Viavi Solutions Inc. is actually cheaper at 54. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Lumentum Holdings Inc.

(LITE) delivered a total return of +1019%, compared to -68. 3% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: LITE returned +36. 8% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Precision Optics Corporation, Inc.

(POCI) is the lower-risk stock at 0. 42β versus Lumentum Holdings Inc. 's 2. 66β — meaning LITE is approximately 531% more volatile than POCI relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for Lumentum Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Lumentum Holdings Inc.

(LITE) is pulling ahead at 21. 0% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Viavi Solutions Inc. grew EPS 225. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -30. 3% for Precision Optics Corporation, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -29. 1% for POCI. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Viavi Solutions Inc.

(VIAV) trades at 54. 7x forward P/E versus 110. 1x for Lumentum Holdings Inc. — 55. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 134. 8% to $46. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Precision Optics Corporation, Inc.

(POCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +240. 0% 10Y return). Lumentum Holdings Inc. (LITE) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (POCI: +240. 0%, LITE: +36. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (POCI (Healthcare) and DBVT (Healthcare) and VIAV (Technology) and ALKS (Healthcare) and LITE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: POCI is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; VIAV is a mid-cap quality compounder stock; ALKS is a small-cap quality compounder stock; LITE is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.